Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
Medtronic plc (NYSE:MDT), the global healthcare technology leader based in Galway, Ireland, has announced its participation in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025. Geoff Martha, chairman and CEO, will deliver a formal presentation and participate in a Q&A session starting at 2:15 p.m. PST.
The presentation and Q&A session will be accessible via live webcast through Medtronic's investor relations website, with an archived version available later that day. Medtronic employs over 95,000 passionate professionals across more than 150 countries, focusing on treating 70 health conditions through various technologies including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems. The company's mission centers on alleviating pain, restoring health, and extending life, helping two people every second globally.
Medtronic plc (NYSE:MDT), leader globale nella tecnologia sanitaria con sede a Galway, Irlanda, ha annunciato la sua partecipazione alla 43ª conferenza annuale sulla sanità di J.P. Morgan che si terrà lunedì 13 gennaio 2025. Geoff Martha, presidente e CEO, terrà una presentazione formale e parteciperà a una sessione di domande e risposte che inizierà alle 14:15 PST.
La presentazione e la sessione di Q&A saranno accessibili tramite web diretta attraverso il sito web delle relazioni con gli investitori di Medtronic, con una versione archiviata disponibile più tardi nel corso della giornata. Medtronic impiega oltre 95.000 professionisti appassionati in più di 150 paesi, concentrandosi sul trattamento di 70 condizioni di salute attraverso diverse tecnologie, tra cui dispositivi cardiaci, robotica chirurgica, pompe per l'insulina e sistemi di monitoraggio dei pazienti. La missione dell'azienda si concentra sull'alleviare il dolore, ripristinare la salute e allungare la vita, aiutando due persone ogni secondo a livello globale.
Medtronic plc (NYSE:MDT), líder mundial en tecnología de salud con sede en Galway, Irlanda, ha anunciado su participación en la 43ª conferencia anual de salud de J.P. Morgan que se llevará a cabo el lunes 13 de enero de 2025. Geoff Martha, presidente y CEO, realizará una presentación formal y participará en una sesión de preguntas y respuestas que comenzará a las 2:15 p.m. PST.
La presentación y la sesión de preguntas y respuestas estarán disponibles a través de una transmisión web en vivo a través del sitio web de relaciones con inversores de Medtronic, con una versión archivada disponible más tarde ese día. Medtronic emplea a más de 95,000 profesionales apasionados en más de 150 países, enfocándose en tratar 70 condiciones de salud mediante diversas tecnologías, incluyendo dispositivos cardíacos, robótica quirúrgica, bombas de insulina y sistemas de monitoreo de pacientes. La misión de la empresa se centra en aliviar el dolor, restaurar la salud y prolongar la vida, ayudando a dos personas cada segundo en todo el mundo.
Medtronic plc (NYSE:MDT), 아일랜드 갈웨이에 본사를 둔 글로벌 의료 기술 리더가 제43회 연례 J.P. 모건 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 행사는 2025년 1월 13일 월요일에 열립니다. Geoff Martha 회장 겸 CEO가 공식 발표를 하고, 오후 2시 15분 PST에 시작되는 Q&A 세션에 참여할 예정입니다.
발표와 Q&A 세션은 Medtronic의 투자자 관계 웹사이트를 통해 실시간 웹 캐스트로 접근 가능하며, 당일 나중에 아카이브 버전도 제공됩니다. Medtronic은 150개 이상의 국가에서 95,000명 이상의 열정적인 전문가를 고용하고 있으며, 70가지 건강 문제를 다양한 기술을 통해 치료하는 데 집중하고 있습니다. 여기에는 심장 기기, 수술 로봇, 인슐린 펌프 및 환자 모니터링 시스템이 포함됩니다. 회사의 사명은 고통을 줄이고, 건강을 회복하며, 삶을 연장하는 것으로, 전 세계적으로 매 초마다 두 사람을 돕고 있습니다.
Medtronic plc (NYSE:MDT), leader mondial en technologie de la santé basé à Galway, en Irlande, a annoncé sa participation à la 43e conférence annuelle sur la santé de J.P. Morgan qui se tiendra le lundi 13 janvier 2025. Geoff Martha, président et CEO, fera une présentation formelle et participera à une session de questions-réponses débutant à 14h15 PST.
La présentation et la session de questions-réponses seront accessibles via un webinaire en direct sur le site web des relations investisseurs de Medtronic, avec une version archivée disponible plus tard dans la journée. Medtronic emploie plus de 95 000 professionnels passionnés dans plus de 150 pays, se concentrant sur le traitement de 70 problèmes de santé grâce à diverses technologies, y compris des dispositifs cardiaques, de la robotique chirurgicale, des pompes à insuline et des systèmes de surveillance des patients. La mission de l'entreprise concerne le soulagement de la douleur, le rétablissement de la santé et l'allongement de la vie, aidant deux personnes chaque seconde dans le monde.
Medtronic plc (NYSE:MDT), der weltweit führende Anbieter von Gesundheitstechnologien mit Sitz in Galway, Irland, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Gesundheitskonferenz am Montag, den 13. Januar 2025, angekündigt. Geoff Martha, Vorsitzender und CEO, wird eine formelle Präsentation halten und an einer Q&A-Sitzung teilnehmen, die um 14:15 Uhr PST beginnt.
Die Präsentation und die Q&A-Sitzung werden über einen Livestream auf der Investor-Relations-Website von Medtronic zugänglich sein, mit einer archivierten Version, die später am Tag verfügbar ist. Medtronic beschäftigt über 95.000 leidenschaftliche Fachleute in mehr als 150 Ländern und konzentriert sich auf die Behandlung von 70 Gesundheitszuständen mit verschiedenen Technologien, darunter kardiologische Geräte, chirurgische Robotik, Insulinpumpen und PatientMonitoringsysteme. Die Mission des Unternehmens besteht darin, Schmerzen zu lindern, Gesundheit wiederherzustellen und Leben zu verlängern und dabei weltweit jede Sekunde zwei Menschen zu helfen.
- None.
- None.
Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company beginning at 2:15 p.m. PST (4:15 p.m. CST). Immediately following the presentation, Martha will be joined by other Medtronic leaders to answer questions on the company.
A live webcast of the presentation and Q&A session will be available on January 13, 2025, by clicking on the Events link at http://investorrelations.medtronic.com. An archive of the presentation and Q&A session will be available on the same webpage later in the day.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts: | |
Erika Winkels | Ryan Weispfenning |
Public Relations | Investor Relations |
+1-763-526-8478 | +1-763-505-4626 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-chairman-and-ceo-geoff-martha-to-speak-at-jp-morgan-healthcare-conference-302343471.html
SOURCE Medtronic plc
FAQ
When is Medtronic (MDT) presenting at the 2025 J.P. Morgan healthcare conference?
How can investors watch Medtronic's (MDT) J.P. Morgan conference presentation?
How many countries does Medtronic (MDT) operate in as of 2025?
What health technologies does Medtronic (MDT) specialize in?
How many people does Medtronic (MDT) employ globally?
How many patients does Medtronic (MDT) impact with their technologies?
